Endothelial dysfunction in renal transplant recipients

Mark, P.B. , Murphy, K., Mohammed, A.S., Morris, S.T.W. and Jardine, A.G. (2005) Endothelial dysfunction in renal transplant recipients. Transplantation Proceedings, 37(9), pp. 3805-3807. (doi:10.1016/j.transproceed.2005.09.116)

Full text not currently available from Enlighten.


Endothelial dysfunction and damage are systemic processes that are recognised to play a central role in the pathogenesis of hypertension and atherosclerotic cardiovascular disease. Renal failure is associated with impaired endothelium dependent vasodilatation that is partly a consequence of increased circulating levels of asymmetric dimethyl arginine. Endothelial dysfunction persists, although it is improved, after renal transplantation. Statins appear to improve endothelial dysfunction, as does withdrawal of calcineurin inhibitors, although there is no evidence that these strategies improve patient or graft survival. The situation in transplant recipients is complicated by the fact that endothelial dysfunction (within the graft vasculature) may be a separate process contributing to chronic allograft nephropathy and to circulating levels of endothelial cells and their components, thus limiting the utility of circulating markers of endothelial damage in this population.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Mark, Dr Patrick and Jardine, Professor Alan
Authors: Mark, P.B., Murphy, K., Mohammed, A.S., Morris, S.T.W., and Jardine, A.G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Transplantation Proceedings
Publisher:Elsevier Inc.
ISSN (Online):1873-2623
Published Online:28 December 2005

University Staff: Request a correction | Enlighten Editors: Update this record